Designing serological assays with high diagnostic potential

In a not-yet peer-reviewed preprint, CITF-funded investigator Dr. Andrei Drabovich and colleagues from the University of Alberta, designed and evaluated the performance of serological diagnostics, used to measure the presence of SARS-CoV-2 antibodies.